Brief: Kala Pharmaceuticals' Application To Transfer Listing Approved By Nasdaq

KALA BIO

10/01/2023 12:18

Jan 10 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA PHARMACEUTICALS - ON JAN 9, RECEIVED LETTER FROM
NASDAQ
NOTIFYING CO THAT ITS APPLICATION TO TRANSFER LISTING HAD BEEN
APPROVED
    * KALA PHARMACEUTICALS INC - CO TO TRANSFER LISTING OF ITS
COMMON
STOCK FROM NASDAQ GLOBAL SELECT MARKET TO NASDAQ CAPITAL MARKET
    * KALA PHARMACEUTICALS INC - TRANSFER WILL BE EFFECTIVE AT
OPENING
OF BUSINESS ON JANUARY 11, 2023
    * KALA PHARMACEUTICALS INC - COMPANY'S COMMON STOCK WILL
CONTINUE
TO TRADE UNDER SYMBOL "KALA."

Source text : (https://bit.ly/3GTH8yw)
Further company coverage:  KALA.O 
 ((Reuters.Briefs@thomsonreuters.com;))